NKGEN BIOTECH INC (NKGN)
Institutional ownership reported to the SEC as of Q2 2026, across 10 quarters.
1
Reporting holders
$165.4K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Meteora Capital, LLC | $165.4K | 2,755,935 | 0.01% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $165.4K | 2,755,935 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $192.9K | 2,755,935 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $137.8K | 2,755,935 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $303.2K | 2,755,935 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 3 | $151.8K | 892,354 | 1 | 0 | 1 | 0.0% |
| Q4 2024 | 23 | $4.9M | 7,623,378 | 7 | 3 | 5 | 0.0% |
| Q3 2024 | 18 | $1.2M | 3,743,367 | 3 | 7 | 2 | 0.0% |
| Q2 2024 | 15 | $4.2M | 3,386,567 | 4 | 4 | 2 | 0.0% |
| Q1 2024 | 13 | $5.7M | 3,018,878 | 6 | 2 | 1 | 0.0% |
| Q4 2023 | 9 | $18.1M | 5,346,769 | 9 | 0 | 0 | 0.0% |